Andrew Lux

The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial

Andrew Lux, Stuart W. Edwards, Eleanor Hancock et al. · The Lancet Neurology · 2005 · 398 citations

Epilepsy Outcomes, Pediatrics, Age 14 +4

The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial

Andrew Lux, Stuart W. Edwards, Eleanor Hancock et al. · The Lancet · 2004 · 374 citations

Pain Disorders, Pediatrics, Pain Management +2

The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study

Finbar O’Callaghan, Andrew Lux, Katrina Darke et al. · Epilepsia · 2011 · 283 citations

Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial

Finbar O’Callaghan, Stuart W. Edwards, Fabienne Dietrich Alber et al. · The Lancet Neurology · 2016 · 281 citations · Full text

Open-label Trial, Pain Disorders, Hormonal Treatment +7

The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification²

John Osborne, Andrew Lux, Stuart W. Edwards et al. · Epilepsia · 2010 · 231 citations · Full text